A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability

Becciolini A, Raimondo MG, Crotti C, Agape E, Biggioggero M, Favalli EG

Drug Design, Development and Therapy 2017, 11:1969-1978

Published Date: 28 June 2017